Tuberculosis
The different types of tuberculosis, its clinical manifestations, pathophysiology, and how it spreads. Discover the signs and symptoms, diagnostic methods, and available treatment options for tuberculosis.
5 views • 23 slides
Mycobacterium Tuberculosis
Tuberculosis is a chronic disease caused by Mycobacterium tuberculosis that primarily affects the respiratory system. This overview covers the epidemiology, transmission methods, causative agents, pathogenesis, diagnostic methods, management, prevention, and control of tuberculosis. The importance o
2 views • 35 slides
Chest Imaging Interpretation for Tuberculosis Screening
Chest imaging plays a crucial role in screening for pulmonary tuberculosis (TB). This activity, led by Dana Kissner from Wayne State University Detroit Tuberculosis Clinic, focuses on interpreting chest imaging results to aid in the diagnosis and management of TB cases. The content includes informat
3 views • 22 slides
Effectiveness of Video Observed Therapy in Tuberculosis Management
Tuberculosis (TB) remains a global health challenge with issues of treatment compliance, cost, and distance to healthcare facilities. A study comparing Video Observed Therapy (VOT) with traditional Directly Observed Treatment Short Course (DOTS) in TB management is conducted to improve compliance, r
1 views • 17 slides
Progress and Initiatives of National Tuberculosis Program in Nepal
The National Tuberculosis Program in Nepal has achieved significant milestones since its inception, including the adoption of strategic initiatives like the Stop TB Strategy and the implementation of DOTS. Various national and international commitments have been made towards ending TB, with a focus
0 views • 46 slides
Active Tuberculosis Drug Safety Monitoring and Management Training Package 2023
This training package focuses on the safety monitoring and management of active tuberculosis drugs, specifically emphasizing causality assessment in determining adverse reactions. Participants will learn about assessing the likelihood of TB medicines causing adverse events, attributing relationships
3 views • 17 slides
Bovine Tuberculosis: A Zoonotic Disease Impacting Humans and Animals
Bovine tuberculosis is a chronic bacterial disease affecting cattle and other mammals, with potential transmission to humans. Endemic in developing countries, it poses public health risks. Modes of transmission, clinical symptoms, diagnosis, and control measures are discussed, highlighting the impor
0 views • 22 slides
Advancements in Tuberculosis Vaccine Development
Explore the importance of developing TB challenge models for vaccine selection, citing challenges such as the long duration and potential toxicity of current treatments. The need for effective vaccines is urgent due to high global TB incidence and mortality rates. Research focuses on human mycobacte
0 views • 19 slides
Overview of Cutaneous Tuberculosis: Causes, Classification, and Clinical Features
Cutaneous tuberculosis is caused by Mycobacterium tuberculosis and its manifestations depend on the host's immunity, route of entry, and bacterial load. It is classified into exogeneous and endogenous sources, with various types such as tuberculides and tuberculous chancre. Clinical features include
0 views • 31 slides
Overview of Antitubercular Drugs: Introduction, Classification, and Applications
Tuberculosis is a chronic granulomatous disease caused by Mycobacterium bovis in ruminants and Mycobacterium avium in dogs and pigs. These bacteria have a unique waxy appearance due to their cell wall composition, providing a shield against pharmacological compounds. Antitubercular drugs play a cruc
3 views • 28 slides
Understanding Tuberculosis of Hip and Knee Joint Deformities
Tuberculosis can affect the hip and knee joints, leading to various deformities and complications if left untreated. Common sites of TB in knee joint, neglected cases due to hamstring contracture, path mechanics of deformity development, along with differential diagnoses and treatment options are di
0 views • 8 slides
Understanding Mycobacterium: Causes and Impact of Tuberculosis
Mycobacterium is a genus of Actinobacteria known for causing serious diseases in mammals, including tuberculosis (TB) and leprosy. Tuberculosis, caused mainly by Mycobacterium tuberculosis, is a chronic infection that affects the lungs and various organs, especially prominent in developing regions d
0 views • 25 slides
Tuberculosis Diagnostics Market
Projecting a $3.56 billion valuation by 2031, the Tuberculosis Diagnostics Market will grow at a 5% CAGR from 2024. Key factors driving this expansion include rising TB incidence in less affluent countries, drug-resistant TB strains, and supportive d
0 views • 3 slides
Tuberculosis Data and Impact Assessment Update - September 13, 2023
Update on Tuberculosis Data, Impact Assessment, and Communications Hub (TB.DIAH) including key indicators such as TB detection rates, childhood TB notifications, treatment success rates, and more. The report highlights important aspects of TB control and monitoring progress across USAID's priority c
0 views • 5 slides
Complications and Presentations of Tuberculosis: A Detailed Overview by Dr. Ruchi Dua
This presentation by Dr. Ruchi Dua, Associate Professor at Aiims Rishikesh, delves into the complications of tuberculosis including local and systemic effects, as well as various presentations of extrapulmonary TB. Topics covered include common complications like respiratory failure, pleural effusio
0 views • 36 slides
Active Tuberculosis Drug Safety Monitoring & Management Training Package 2023
This training package focuses on the implementation of active tuberculosis drug safety monitoring and management (aDSM) in 2023. It covers the role of national and international partners, learning objectives, key steps in aDSM implementation, creating a national coordinating mechanism, developing a
0 views • 14 slides
Comprehensive Guide on Active Tuberculosis Drug Safety Monitoring and Management (aDSM) Implementation
This comprehensive guide provides key steps and timelines for implementing Active Tuberculosis Drug Safety Monitoring and Management (aDSM). It covers the development of a plan, defining roles and responsibilities, data collection, training, and electronic data consolidation. The timeline includes a
0 views • 20 slides
Building Capacity for Active Tuberculosis Drug Safety Monitoring and Management
This training package focuses on developing capacity for signal detection and causality assessment in the management of active tuberculosis drug safety. Key steps include creating a national coordinating mechanism, defining roles and responsibilities, training staff, and consolidating data electroni
0 views • 12 slides
Comprehensive Training Package on Active Tuberculosis Drug Safety Monitoring and Management (aDSM) 2023
This training package focuses on signal detection in active tuberculosis drug safety monitoring. It covers the main aims and principles of signal detection, completion of safety profiles for new TB drugs and regimens, definition of signal, continuous reporting activities, construction of risk profil
5 views • 15 slides
Understanding Tuberculosis: A Comprehensive Overview of the Disease
Tuberculosis, a chronic disease affecting both humans and animals, is caused by pathogenic Mycobacterium spp. This article covers the etiology, synonyms, history, and geographic distribution of tuberculosis, along with key terms like anthropozoonosis and zooanthroponosis. Learn about the tubercle ba
0 views • 24 slides
Guidelines for Tuberculosis Screening and Reporting in Chapter 89 Designated Facilities
Guidelines outlined in Chapter 89 for designated facilities in Texas include screening requirements, common terminology, reporting procedures, and conversion scenarios for tuberculosis testing. The definition of a Chapter 89-designated facility, screening guidelines, and reporting requirements are c
1 views • 18 slides
Update on Health Statistics in Samoa
The health statistics in Samoa reveal challenges and progress in managing HIV, syphilis, and tuberculosis cases. As of 2021, there are 13 people living with HIV in Samoa, with an increase in syphilis cases compared to the previous year. The country has seen no patients with multi-drug-resistant tube
0 views • 20 slides
Adjuvant Therapies in Early Stage NSCLC: A Review
Examining the role of adjuvant therapies in stage IB-IIIA non-small cell lung cancer (NSCLC) post-surgery. Discussion includes the impact of chemotherapy and radiation therapy on overall survival rates and the historical context of adjuvant treatment decisions. Management strategies and consideratio
0 views • 30 slides
Evolution of Tuberculosis: From Ancient Origins to Modern Challenges
Tuberculosis, an ancient disease possibly acquired from domesticated animals thousands of years ago, has transitioned from endemic to epidemic in human populations. The causative agent, M. tuberculosis, was identified by Robert Koch in 1882. Over the years, public health efforts, improved nutrition,
0 views • 34 slides
Tuberculosis Treatment Completion Among Incarcerated Persons in the U.S. (1999-2008)
Tuberculosis treatment completion among incarcerated individuals is crucial for TB control, with incomplete treatment leading to increased risks. The national target for treatment completion within 12 months stands at 93%. Overall, the completion rate improved but falls short of this goal, with vari
0 views • 18 slides
Tuberculosis Diagnostics Market
The Tuberculosis Diagnostics Market is on track to achieve a value of $3.56 billion by 2031, fueled by a 5% CAGR from 2024. Explore the market's significant growth drivers and stay ahead of the curve by understanding future trends in TB diagnostics.\
0 views • 4 slides
Integrating Nutrition Assessment and Counselling for Clients with Active Tuberculosis
This training course emphasizes the critical relationship between nutrition and tuberculosis (TB), highlighting how undernutrition impacts TB infection and the implications of TB-HIV co-infections on nutritional status. Participants will learn about managing nutrition for individuals with active TB,
0 views • 29 slides
Understanding Tuberculosis of the Skin: Clinical Aspects, Diagnosis, and Treatment
This comprehensive guide explores the different types of tuberculosis affecting the skin, including localized and generalized forms, as well as tuberculide. It covers clinical features, diagnostic methods like the tuberculin test, and treatment recommendations for conditions such as lupus vulgaris.
1 views • 29 slides
Public Health and Tuberculosis: A Focus on XDR-TB in Howard County, Maryland
The evolving role of public health in addressing tuberculosis, specifically extensively drug-resistant tuberculosis (XDR-TB), in Howard County, Maryland is highlighted in this presentation. The county's demographics, TB cases over the years, and a pediatric XDR-TB case are discussed, emphasizing the
1 views • 22 slides
Managing Drug Interactions and Side Effects in HIV/AIDS and Tuberculosis Therapies
Learn how to identify common therapies used in HIV/AIDS and TB treatment, understand drug-food interactions and side effects, and provide appropriate nutrition assessment and support to improve treatment outcomes. Service providers play a crucial role in addressing nutritional needs and managing dru
0 views • 34 slides
Understanding Phagocytosis, Inflammation, and Granulomas in Tuberculosis
Phagocytosis is a crucial process where cells engulf and digest pathogens. Inflammation responses involve various immune cells like neutrophils, plasma cells, lymphocytes, and macrophages. Granulomas, typical in diseases like tuberculosis, are mass accumulations in chronic inflammation. Tuberculosis
0 views • 18 slides
Understanding Tuberculosis Prevention and Vaccination
Learn about the fundamentals of tuberculosis prevention, the types of vaccines available, and current vaccines like Bacille Calmette-Guérin (BCG). Discover the limitations of the BCG vaccine and target populations for vaccination to combat tuberculosis effectively.
0 views • 25 slides
Training Package on Active Tuberculosis Drug Safety Monitoring and Management (aDSM) 2023
This presentation focuses on organizing the training of key staff to collect data for active tuberculosis drug safety monitoring. It covers the proper use of standard forms and treatment cards to ensure systematic and efficient data collection, along with reporting procedures for adverse events. Par
0 views • 21 slides
Disease Tabletop Exercise: Suspected Tuberculosis Response Plan
Local health jurisdictions in Montana are preparing for disease tabletop exercises focusing on activating emergency response plans for suspected tuberculosis cases. The exercise aims to engage public health partners, clarify response roles, and identify strengths and gaps in emergency preparedness p
0 views • 49 slides
Understanding Brainspotting and Power Therapies for Trauma Healing
Participants in this workshop will explore Brainspotting (BSP) and other Power Therapies, learning about trauma, its effects, and the power of therapies such as EMDR, TFT/EFT, HAKOMI, PBSP, and more in addressing trauma and promoting healing through heightened bodily awareness and somatic memory ret
0 views • 19 slides
Understanding Tuberculosis: Causes, Symptoms, and Prevention Measures
Tuberculosis (TB) is caused by Mycobacterium tuberculosis bacteria and primarily affects the lungs but can impact other body parts. TB can be latent or active, with symptoms like fever, weight loss, and coughing. Prevention involves protective strategies during autopsies and universal precautions. E
0 views • 10 slides
Comprehensive Training Package on Active Tuberculosis Drug Safety Monitoring and Management (aDSM) 2023
This comprehensive training package focuses on active tuberculosis drug safety monitoring and management (aDSM) in 2023. It covers indicators, learning objectives, and essential information for implementing effective drug safety measures in tuberculosis treatment. The presentation emphasizes definin
0 views • 11 slides
Understanding and Implementing Non-Drug Therapies for Pain in Older Adults
This resource provides information on the role of direct care workers in identifying and addressing pain in older adults, funded by The SCAN Foundation. It covers misconceptions about non-drug approaches to pain, various non-drug therapies like physical positioning and music, and tips on when to use
0 views • 47 slides
Tuberculosis as a Risk Factor for Viral Non-Suppression in Patients Switched to Dolutegravir-Based Therapy
The study investigates the impact of incident tuberculosis on viral non-suppression among patients transitioning to Dolutegravir-based therapy in Zambia. It aims to identify factors associated with viral non-suppression and describe clinical outcomes in the context of tuberculosis occurrence. The re
0 views • 13 slides
Study on Long-Acting Therapies and Virologic Outcomes in HIV Treatment
Faculty from different parts of the world presented at the Conference on Retroviruses and Opportunistic Infections in 2023, discussing a randomized study comparing long-acting therapies to oral treatment for HIV. The study, known as SOLAR, showed promising results in virologic outcomes at the 12-mon
0 views • 41 slides